AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-5.1%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$11.7B
AUM Growth
-$492M
(-4%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
50.91%
Holding
702
New
40
Increased
578
Reduced
62
Closed
22
Top Buys
| 1 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
$149M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
$66.6M |
| 3 |
ENLK
EnLink Midstream Partners, LP
ENLK
|
$57.2M |
| 4 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$36.9M |
| 5 |
NGL Energy Partners
NGL
|
$31.6M |
Top Sells
Sector Composition
| 1 | Energy | 69.51% |
| 2 | Materials | 2.13% |
| 3 | Healthcare | 1.96% |
| 4 | Consumer Discretionary | 1.58% |
| 5 | Financials | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
126
New Gold Inc
NGD
$4.99B
| $4.19M | 0.04% |
1,557,544
+995,848
| +177% | +$2.68M |
|
127
Kinross Gold
KGC
$26.9B
| $4.17M | 0.04% |
1,797,483
+553,644
| +45% | +$1.28M |
|
128
Acadia Pharmaceuticals
ACAD
$4.26B
| $4.17M | 0.04% |
99,533
+49,968
| +101% | +$2.09M |
|
129
Sandstorm Gold
SAND
$3.37B
| $4.08M | 0.03% |
1,387,822
+318,183
| +30% | +$935K |
|
130
Neurocrine Biosciences
NBIX
$14.3B
| $4.05M | 0.03% |
84,773
+43,292
| +104% | +$2.07M |
|
131
Simon Property Group
SPG
$59.5B
| $3.87M | 0.03% |
22,358
+1,232
| +6% | +$213K |
|
|
DYAX
132
DELISTED
DYAX CORPORATION
DYAX
| $3.83M | 0.03% |
144,550
+76,743
| +113% | +$2.03M |
|
133
NiSource
NI
$19B
| $3.77M | 0.03% |
210,179
+90,869
| +76% | +$1.63M |
|
134
Ultragenyx Pharmaceutical
RARE
$3.07B
| $3.65M | 0.03% |
35,630
+18,326
| +106% | +$1.88M |
|
|
CTLT
135
DELISTED
CATALENT, INC.
CTLT
| $3.62M | 0.03% |
+123,359
| New | +$3.62M |
|
136
NovaGold Resources
NG
$2.75B
| $3.56M | 0.03% |
1,042,173
+645,659
| +163% | +$2.21M |
|
|
PVG
137
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.47M | 0.03% |
+640,406
| New | +$3.47M |
|
138
Public Storage
PSA
$52.2B
| $3.36M | 0.03% |
18,231
+199
| +1% | +$36.7K |
|
|
ANAC
139
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $3.36M | 0.03% |
43,395
+22,053
| +103% | +$1.71M |
|
|
IPXL
140
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.27M | 0.03% |
71,173
+35,748
| +101% | +$1.64M |
|
141
Equity Residential
EQR
$25.5B
| $3.21M | 0.03% |
45,743
+896
| +2% | +$62.9K |
|
142
Targa Resources
TRGP
$34.9B
| $3.16M | 0.03% |
35,421
-4,042
| -10% | -$361K |
|
|
CLVS
143
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.97M | 0.03% |
33,756
+16,810
| +99% | +$1.48M |
|
144
Welltower
WELL
$112B
| $2.88M | 0.02% |
43,919
+1,298
| +3% | +$85.2K |
|
145
Halozyme
HALO
$8.76B
| $2.85M | 0.02% |
126,319
+64,009
| +103% | +$1.45M |
|
|
MON
146
DELISTED
Monsanto Co
MON
| $2.77M | 0.02% |
25,957
-652
| -2% | -$69.5K |
|
147
Ligand Pharmaceuticals
LGND
$3.25B
| $2.69M | 0.02% |
42,722
+15,747
| +58% | +$991K |
|
148
AvalonBay Communities
AVB
$27.8B
| $2.65M | 0.02% |
16,556
+227
| +1% | +$36.3K |
|
149
Ventas
VTR
$30.9B
| $2.58M | 0.02% |
36,388
+1,719
| +5% | +$122K |
|
150
Pacira BioSciences
PCRX
$1.19B
| $2.56M | 0.02% |
36,170
+18,135
| +101% | +$1.28M |
|